Evonik is one of the world's leading specialty chemicals companies. Profitable growth and sustained value creation form the heart of our strategy. Around 80 percent of sales come from leading market positions, which we plan to expand further. We concentrate on high-growth megatrends, especially health, nutrition, resource efficiency and globalization.
In 2012 Evonik’s roughly 33,000 employees generated sales of €13.6 billion and an operating result (adjusted EBITDA) of €2.6 billion. 75 percent of sales are generated outside Germany, providing convincing evidence that our business is global.